Wright Medical Group N.V. (WMGI) versus ReWalk Robotics (RWLK) Financial Contrast

Wright Medical Group N.V. (NASDAQ: WMGI) and ReWalk Robotics (NASDAQ:RWLK) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, profitability, earnings, institutional ownership and dividends.

Insider & Institutional Ownership

4.7% of ReWalk Robotics shares are owned by institutional investors. 9.3% of Wright Medical Group N.V. shares are owned by insiders. Comparatively, 13.7% of ReWalk Robotics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Profitability

This table compares Wright Medical Group N.V. and ReWalk Robotics’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Wright Medical Group N.V. -36.04% -6.22% -1.81%
ReWalk Robotics -389.13% -528.26% -101.87%

Risk & Volatility

Wright Medical Group N.V. has a beta of 0.72, indicating that its share price is 28% less volatile than the S&P 500. Comparatively, ReWalk Robotics has a beta of 0.88, indicating that its share price is 12% less volatile than the S&P 500.

Analyst Ratings

This is a summary of current ratings and price targets for Wright Medical Group N.V. and ReWalk Robotics, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Wright Medical Group N.V. 0 4 7 0 2.64
ReWalk Robotics 1 0 3 0 2.50

Wright Medical Group N.V. currently has a consensus target price of $32.25, suggesting a potential upside of 16.01%. ReWalk Robotics has a consensus target price of $4.63, suggesting a potential upside of 230.36%. Given ReWalk Robotics’ higher possible upside, analysts clearly believe ReWalk Robotics is more favorable than Wright Medical Group N.V..

Valuation and Earnings

This table compares Wright Medical Group N.V. and ReWalk Robotics’ gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio EBITDA Earnings Per Share Price/Earnings Ratio
Wright Medical Group N.V. $707.24 million 4.10 $58.57 million ($2.46) -11.30
ReWalk Robotics $7.50 million 3.11 -$24.63 million ($1.94) -0.72

Wright Medical Group N.V. has higher revenue and earnings than ReWalk Robotics. Wright Medical Group N.V. is trading at a lower price-to-earnings ratio than ReWalk Robotics, indicating that it is currently the more affordable of the two stocks.

Summary

Wright Medical Group N.V. beats ReWalk Robotics on 8 of the 13 factors compared between the two stocks.

Wright Medical Group N.V. Company Profile

Wright Medical Group, Inc. is a global specialty orthopaedic company. The Company through Wright Medical Technology, Inc. (WMT) and other subsidiaries provides extremity and biologic solutions that enable clinicians to alleviate pain and restore the patients’ lifestyles. The Company operates through three segments: U.S., International and BioMimetic. The Company’s business includes products that are used in foot and ankle repair, upper extremity products and biologics products, which are used to replace damaged or diseased bone, to stimulate bone growth and to provide other biological solutions for surgeons and patients. The Company’s products include extremity hardware, foot and ankle hardware, upper extremity hardware and biologics.

ReWalk Robotics Company Profile

ReWalk Robotics Ltd. is a medical device company. The Company is engaged in designing, developing and commercializing exoskeletons that allow individuals with mobility impairments or other medical conditions the ability to stand and walk once again. The Company offers ReWalk, which is an exoskeleton that uses its tilt-sensor technology and an on-board computer and motion sensors to drive motorized legs that power movement. ReWalk designs are intended for people with paraplegia, a spinal cord injury resulting in complete or incomplete paralysis of the legs, having the use of their upper bodies and arms. The Company offers two ReWalk products: ReWalk Personal and ReWalk Rehabilitation. ReWalk Personal is designed for everyday use by paraplegic individuals at home and in their communities, and is custom fitted for each user. ReWalk Rehabilitation is designed for use by paraplegia patients in the clinical rehabilitation environment, where it provides exercise and therapy.

Receive News & Ratings for Wright Medical Group N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Wright Medical Group N.V. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply